Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1973 1
1975 1
1976 1
1978 1
1979 1
1980 1
1982 1
1984 1
1988 1
1991 2
1995 2
1996 3
1997 3
1998 2
1999 6
2000 4
2001 4
2002 7
2003 2
2004 2
2005 6
2006 7
2007 14
2008 8
2009 12
2010 22
2011 17
2012 11
2013 25
2014 15
2015 23
2016 10
2017 11
2018 18
2019 26
2020 22
2021 36
2022 41
2023 36
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

385 results

Results by year

Filters applied: . Clear all
Page 1
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
Moore KN, Angelergues A, Konecny GE, García Y, Banerjee S, Lorusso D, Lee JY, Moroney JW, Colombo N, Roszak A, Tromp J, Myers T, Lee JW, Beiner M, Cosgrove CM, Cibula D, Martin LP, Sabatier R, Buscema J, Estévez-García P, Coffman L, Nicum S, Duska LR, Pignata S, Gálvez F, Wang Y, Method M, Berkenblit A, Bello Roufai D, Van Gorp T; Gynecologic Oncology Group Partners and the European Network of Gynaecological Oncological Trial Groups. Moore KN, et al. Among authors: garcia y. N Engl J Med. 2023 Dec 7;389(23):2162-2174. doi: 10.1056/NEJMoa2309169. N Engl J Med. 2023. PMID: 38055253 Clinical Trial.
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39).
Moore KN, Bookman M, Sehouli J, Miller A, Anderson C, Scambia G, Myers T, Taskiran C, Robison K, Mäenpää J, Willmott L, Colombo N, Thomes-Pepin J, Liontos M, Gold MA, Garcia Y, Sharma SK, Darus CJ, Aghajanian C, Okamoto A, Wu X, Safin R, Wu F, Molinero L, Maiya V, Khor VK, Lin YG, Pignata S. Moore KN, et al. Among authors: garcia y. J Clin Oncol. 2021 Jun 10;39(17):1842-1855. doi: 10.1200/JCO.21.00306. Epub 2021 Apr 23. J Clin Oncol. 2021. PMID: 33891472 Free PMC article. Clinical Trial.
Influence of Aquatic Therapy in Children and Youth with Cerebral Palsy: A Qualitative Case Study in a Special Education School.
Muñoz-Blanco E, Merino-Andrés J, Aguilar-Soto B, García YC, Puente-Villalba M, Pérez-Corrales J, Güeita-Rodríguez J. Muñoz-Blanco E, et al. Among authors: garcia yc. Int J Environ Res Public Health. 2020 May 23;17(10):3690. doi: 10.3390/ijerph17103690. Int J Environ Res Public Health. 2020. PMID: 32456241 Free PMC article.
Functions of the Hsp90-binding FKBP immunophilins.
Guy NC, Garcia YA, Sivils JC, Galigniana MD, Cox MB. Guy NC, et al. Among authors: garcia ya. Subcell Biochem. 2015;78:35-68. doi: 10.1007/978-3-319-11731-7_2. Subcell Biochem. 2015. PMID: 25487015 Review.
Rational Discovery of Microtubule-Stabilizing Peptides.
Úsuga-Acevedo B, García Y, Díaz CF, Jiménez VA. Úsuga-Acevedo B, et al. Among authors: garcia y. J Chem Inf Model. 2022 Dec 26;62(24):6844-6856. doi: 10.1021/acs.jcim.2c00849. Epub 2022 Sep 8. J Chem Inf Model. 2022. PMID: 36074453
Neuroendocrinology-based therapy for Alzheimer's disease.
Palm R, Ayala-Fontanez N, Garcia Y, Lee HG, Smith MA, Casadesus G. Palm R, et al. Among authors: garcia y. Biofactors. 2012 Mar-Apr;38(2):123-32. doi: 10.1002/biof.1011. Epub 2012 Mar 22. Biofactors. 2012. PMID: 22438197 Review.
Functions of the Hsp90-Binding FKBP Immunophilins.
Ortiz NR, Guy N, Garcia YA, Sivils JC, Galigniana MD, Cox MB. Ortiz NR, et al. Among authors: garcia ya. Subcell Biochem. 2023;101:41-80. doi: 10.1007/978-3-031-14740-1_2. Subcell Biochem. 2023. PMID: 36520303
Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations.
Schouten PC, Schmidt S, Becker K, Thiele H, Nürnberg P, Richters L, Ernst C, Treilleux I, Medioni J, Heitz F, Pisano C, Garcia Y, Petru E, Hietanen S, Colombo N, Vergote I, Nagao S, Linn SC, Pujade-Lauraine E, Ray-Coquard I, Harter P, Hahnen E, Schmutzler RK. Schouten PC, et al. Among authors: garcia y. JAMA Netw Open. 2024 Apr 1;7(4):e245552. doi: 10.1001/jamanetworkopen.2024.5552. JAMA Netw Open. 2024. PMID: 38592722 Free PMC article. Clinical Trial.
A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS).
Griffiths-Jones DJ, Garcia YS, Ryder WD, Pauling JD, Hall F, Lanyon P, Bhat S, Douglas K, Gunawardena H, Akil M, Anderson M, Griffiths B, Del Galdo F, Youssef H, Madhok R, Arthurs B, Buch M, Fligelstone K, Zubair M, Mason JC, Denton CP, Herrick AL. Griffiths-Jones DJ, et al. Among authors: garcia ys. Rheumatology (Oxford). 2023 Sep 1;62(9):3133-3138. doi: 10.1093/rheumatology/kead012. Rheumatology (Oxford). 2023. PMID: 36637209 Free PMC article. Clinical Trial.
385 results